Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -80.942\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCCCNc1ncnc2sc3c(c12)CCN(CCC)C3
(b) Cc1nc(Sc2ccccc2)c(C#N)c(C)c1[N+](=O)[O-]
Answer: a. CCCCNc1ncnc2sc3c(c12)CCN(CCC)C3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCNc1ncnc2sc3c(c12)CCN(CCC)C3
CCCCNc1ncnc2sc3c(c12)CCN(CCC)C3
N-butyl-11-propyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-amine